Browsing by Author "Ozaras, Resat"
Now showing items 1-6 of 6
-
Does resolved HBV or anti-HBc-only carry the same risk of HBV reactivation?
Ozaras, Resat; Uraz, Suleyman; Demirel, Aslihan; Mete, Bilgul; Tabak, Fehmi (SAGE PUBLICATIONS LTD, 2018)… -
First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment
Ozaras, Resat; Mete, Bilgul; Ceylan, Bahadir; Ozgunes, Nail; Gunduz, Alper; Karaosmanoglu, Hayat; Tabak, Fehmi (LIPPINCOTT WILLIAMS & WILKINS, 2014)Background Hepatitis B virus (HBV) infection is a health problem worldwide. Current treatment options for chronic hepatitis B (CHB) are nucleoside or nucleotide analogues and pegylated interferons. Tenofovir and entecavir ... -
Hemoptysis in COVID-19: Pulmonary Emboli Should be Ruled Out
Ozaras, Resat; Uraz, Suleyman (Korean Radiological Soc, 2020)[No abstract available] -
On hepatitis B virus and vasculitis
Ozaras, Resat; Demirel, Aslihan; Uraz, Suleyman; Mete, Bilgul; Tabak, Fehmi (SPRINGER HEIDELBERG, 2018)… -
Resolved hepatitis B virus infection: an unresolved issue of terminology
Ozaras, Resat; Uraz, Suleyman; Demirel, Aslihan; Mete, Bilgul; Tabak, Fehmi (LIPPINCOTT WILLIAMS & WILKINS, 2018)…
